Royal Philips NV (PHG)

Enhanced applications for neurology, cardiology and oncology help clinicians analyze and compare medical images, evaluate treatment options, and track therapy response over time

Showcases continued commitment to creating innovative solutions that enhance and simplify the clinical decision making path, from diagnosis to treatment, to drive more personalized care

Former Olympic gold medalist, David Plummer, joins Philips to discuss his journey with sleep apnea treatment

- Debuts IntelliSpace Oncology, an integrated oncology informatics solution enabling data-driven decision making and proactive patient involvement across care teams

- New "turnkey" approach to precision medicine seeks to deliver Intermountain's best practices into a streamlined service to be integrated at the point of care

- Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and between tumors

Study showed use of home non-invasive ventilation in conjunction with home oxygen therapy delayed hospital readmissions for patients with advanced disease

Royal Philips (NYSE:PHG, AEX:PHIA) today announced the results of its second annual Future Health Index (FHI), an international study of the general population and healthcare professionals that examines their views...

Philips TrueVue, GlassVue and aReveal(A.I.) improve workflow and diagnostic confidence, enhancing the connection between clinicians and their patients

Van Houten was speaking at the World Medical Innovation Forum in Boston.

Researchers find automated 3D Echocardiographic analysis of left-heart chambers an accurate alternative to manual methodology

The Dutch medical devices makers is up more than 3% after first quarter cost savings helped it to beat net income expectations by about 50%.

Highlights work with the University of Vermont to advance neuro imaging with Philips' newest neurological clinical application, MultiBand SENSE

Multifaceted approach to treatment offers significant financial benefits while improving quality of patient care

- First digital pathology solution to be cleared for primary diagnostic use in the U.S.

Advanced CPAP offers same clinically-proven therapy as Philips' award-winning DreamStation at half the size for reliable, uninterrupted therapy while on-the-go

Leading healthcare organization implements population health management tools to reduce hospital stays and readmission, eases the burden of critical care shortage

- Patient outcome data from the DEFINE FLAIR and iFR Swedeheart trials, published in the New England Journal of Medicine, has potential to positively impact the use and adoption of iFR-guided assessment of heart disease

Debuting at the International Home and Housewares Show in Chicago, IL March 18-21, attendees will experience the Philips Air Purifiers first-hand, alongside new kitchen appliances from Philips

Debuting at the International Home and Housewares Show in Chicago, IL March 18-21, attendees will experience the Philips Air Purifiers first-hand, alongside new kitchen appliances from Philips

- Survey finds only 1 in 10 employed adults across the globe value their job over a good night's sleep, but pressures in U.S. seem greater

- The integration of imaging data with clinical informatics and advanced analytics to drive actionable insights to improve outcomes for patients with cardiovascular diseases

Royal Philips (NYSE: PHG, AEX: PHIA) a leading health technology company, and Phoenix Children's Hospital, a U.

New DreamStation Advanced Therapies use clinically-proven algorithms to support a wider range of patients suffering from complex breathing disorders